<DOC>
	<DOCNO>NCT02670889</DOCNO>
	<brief_summary>The purpose study determine acetohydroxamic acid ( AHA ) prevent hydrolysis urea inhibit bacterial urease gut flora healthy control adult well adult urea cycle disorder .</brief_summary>
	<brief_title>Urease Inhibitor Drug Treatment Urea Cycle Disorders</brief_title>
	<detailed_description />
	<mesh_term>Urea Cycle Disorders , Inborn</mesh_term>
	<mesh_term>Ornithine Carbamoyltransferase Deficiency Disease</mesh_term>
	<mesh_term>Citrullinemia</mesh_term>
	<mesh_term>Argininosuccinic Aciduria</mesh_term>
	<mesh_term>Acetohydroxamic acid</mesh_term>
	<criteria>For Healthy Adult Volunteers : Compliant receive medication orally intravenously Compliant provide blood urine sample For Urea Cycle Disorder Adults : Compliant receive medication orally intravenously Compliant provide blood urine sample Established diagnosis CPSD , OTCD , ASSD ASLD follow : Diagnosis CPS I deficiency , define decrease ( less 20 % control ) CPS I enzyme activity liver identify pathogenic mutation Diagnosis OTC deficiency , define identification pathogenic mutation , linkage analysis affect family , less 20 % control OTC activity liver , elevate urinary orotate ( great 20 uM/mM ) random sample follow allopurinol load absence argininosuccinic acid Diagnosis AS deficiency ( Citrullinemia ) , define great equal 10fold elevation citrulline plasma , decrease AS enzyme activity culture skin fibroblast appropriate tissue , identification pathogenic mutation AS gene Diagnosis AL deficiency ( Argininosuccinic Aciduria , ASA ) , define presence argininosuccinic acid blood urine , decrease AL enzyme activity culture skin fibroblast appropriate tissue , identification pathogenic mutation AL gene Exclusion Criteria ( arm ) : Current prior Helicobacter pylorus infection Chronic gastrointestinal illness ( e.g. , inflammatory bowel disease ) Chronic renal failure Taking probiotic medication within week study start date Currently pregnant lactate . Documentation negative pregnancy test within week prior test require , unless premenarchal menopausal , experience menses week , circumstance preclude pregnancy ( e.g . hysterectomy ) . Presence acute infection time inclusion Participation clinical interventional trial receive experimental medication within last 30 day Any clinical laboratory abnormality medical condition , discretion investigator , may put subject additional risk participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Urea Cycle Disorder</keyword>
</DOC>